Newark, NJ, June 5, 2013 — Buchanan Ingersoll & Rooney PC announced today that Genevieve M. Spires joined the firm’s FDA and Pharmaceuticals Section as counsel. Spires previously practiced at a New Jersey-based law firm.

“Buchanan Ingersoll & Rooney is expanding its FDA practice in New Jersey, which is complemented by the firm’s Washington, D.C.-based FDA practice,” explained Spires. “The firm’s depth in life sciences and FDA compliance, the ability to practice with former FDA and CMS attorneys, and the firm’s national platform made this an attractive move for me,” she added.

Spires provides counsel on the laws and industry standards applicable to the sale and marketing of pharmaceuticals and medical devices. She joins Buchanan’s prominent FDA practice, which includes members from offices in Newark, Princeton, New York and Washington, D.C. Shareholder Linda Pissot Reig, who joined the firm in February of 2011, heads up the practice locally.

About Spires
In addition to counseling clients on FDA regulatory issues, Spires has experience defending pharmaceutical, medical device, industrial and consumer product manufacturers in product liability suits, including mass torts, federal multi-district litigation, class actions and individual state and federal suits in New Jersey, New York and other jurisdictions.

Spires received her J.D. degree from Rutgers University School of Law-Newark, where she was editor-in-chief of Rutgers Law Review. She received her B.A. degree from The Ohio State University.

About the Firm
Buchanan Ingersoll & Rooney PC ( has more than 450 attorneys and government relations professionals practicing throughout the United States, with offices in California, Delaware, Florida, New Jersey, New York, North Carolina, Pennsylvania, Virginia and Washington, D.C. ###